Health Canada
- Status: approved
Human Recombinant Regular Insulin infusion (Human Recombinant Regular Insulin infusion) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Wanpen Vongpatanasin is the originator. The local marketing authorisation holder may differ — check the official source linked above.